Ratings Ion Beam Applications, SA

Equities

IBAB

BE0003766806

Market Closed - Euronext Bruxelles Other stock markets 11:35:13 2024-05-03 am EDT			5-day change	1st Jan Change
13.74 ^EUR	+4.89%		+6.84%	+19.06%

May. 02	Ion Beam Applications SA Signs Contract with Yale New Haven Health and Hartford HealthCare to Install Proteus®?One Proton Therapy Solution in Connecticut, US	CI
Mar. 21	Ion Beam Applications SA to Recommend Dividend for 2023	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Strengths

The company's profit outlook over the next few years is a strong asset.
With regards to fundamentals, the enterprise value to sales ratio is at 0.7 for the current period. Therefore, the company is undervalued.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
With an expected P/E ratio at 98.14 and 14.93 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company appears highly valued given the size of its balance sheet.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Advanced Medical Equipment & Technology

	1st Jan change	Capi.	ESG Refinitiv
ION BEAM APPLICATIONS, SA	+19.06%	432M	B+
THERMO FISHER SCIENTIFIC	+7.84%	218B	B
DANAHER CORPORATION	+7.35%	184B	B-
INTUITIVE SURGICAL, INC.	+13.04%	135B	B-
BOSTON SCIENTIFIC CORPORATION	+26.03%	107B	A-
SIEMENS HEALTHINEERS AG	-1.33%	62.38B	A-
EDWARDS LIFESCIENCES CORPORATION	+11.80%	51.37B	B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.9B	B+
AGILENT TECHNOLOGIES, INC.	+0.30%	40.87B	A
GE HEALTHCARE TECHNOLOGIES INC.	+2.78%	36.28B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes